Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
Recruiting · NCT06630624 · Registry updated 2025-07-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 1 / Phase 2 | 2025-07-03 | NCT06630624 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Angiodynamics, Inc. | 15 |
| Immunophotonics, Inc. | 3 |
| M.R. Meijerink | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam UMC - location VUmc | Amsterdam | Netherlands | 1 |